Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Enhanced delivery of camptothecin to colorectal carcinoma using a tumor-penetrating peptide targeting p32

Acta Biomaterialia(2025)10.1016/j.actbio.2025.05.036Source: DataRank Database

Enhanced delivery of camptothecin to colorectal carcinoma using a tumor-penetrating peptide targeting p32 is a research paper published in Acta Biomaterialia (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

5 citations

Download PDF

Cite:

Linked data & code

gen uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.38)OA: closedTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Zhiren Wang ORCID,Wenpan Li ORCID,Teng Ma ORCID,Mengwen Li ORCID,Shuang Wu ORCID

Live enrichment

PubMed:40379119 PMC:PMC12182993 OpenAlex:https://openalex.org/W4410350057

Foundation for the National Institutes of Health

Grant: R35GM147002

National Institutes of Health

Grant: R01CA272487

National Cancer Institute

Grant: P30 CA023074

National Institute of Environmental Health Sciences

Grant: P30 ES006694

The University of Arizona

Pharmaceutical Research and Manufacturers of America Foundation

FWCI

2.38

Citation Percentile

0.9%

Citation Trend

2025

2026

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S1742706125003617?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1742706125003617?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.actbio.2025.05.036

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40379119

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12182993

Fields of Study

Cancer therapeutics and mechanismsPeptidase Inhibition and AnalysisRNA Interference and Gene Delivery

MeSH Terms

AnimalsCamptothecinHumansMice, NudeNeoplasm ProteinsColorectal NeoplasmsDrug Delivery SystemsXenograft Model Antitumor AssaysHCT116 CellsMiceCell-Penetrating Peptides

Keywords

CamptothecinPeptideMaterials scienceCancer researchColorectal cancerOncologyMedicineInternal medicineCancerBiologyBiochemistryP32NanotherapeuticsCamptothesomeTumor-homing Lintt1 Peptide

Sustainable Development Goals

SDG 0: Good health and well-being

Enhanced delivery of camptothecin to colorectal carcinoma using a tumor-penetrating peptide targeting p32

FAIR Checklist

Authors (13)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)